Esperion Therapeutics, Inc. Quarterly Return On Assets in % from Q1 2014 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Esperion Therapeutics, Inc. quarterly/annual Return On Assets history and growth rate from Q1 2014 to Q3 2024.
  • Esperion Therapeutics, Inc. Return On Assets for the quarter ending September 30, 2024 was -27.9 %, a 68% increase year-over-year.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2023 was -91.6 %, a 18.4% decline from 2022.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2022 was -77.4 %, a 16.2% increase from 2021.
  • Esperion Therapeutics, Inc. annual Return On Assets for 2021 was -92.3 %, a 79.2% decline from 2020.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -27.9 +59.4 +68% Jul 1, 2024 Sep 30, 2024
Q2 2024 -34.2 +50.7 +59.7% Apr 1, 2024 Jun 30, 2024
Q1 2024 -33.4 +52.1 +60.9% Jan 1, 2024 Mar 31, 2024
Q4 2023 -91.6 -14.2 -18.4% Oct 1, 2023 Dec 31, 2023
Q3 2023 -87.2 -14.7 -20.2% Jul 1, 2023 Sep 30, 2023
Q2 2023 -84.9 -2.72 -3.31% Apr 1, 2023 Jun 30, 2023
Q1 2023 -85.5 -9.11 -11.9% Jan 1, 2023 Mar 31, 2023
Q4 2022 -77.4 +14.9 +16.2% Oct 1, 2022 Dec 31, 2022
Q3 2022 -72.6 +35.9 +33.1% Jul 1, 2022 Sep 30, 2022
Q2 2022 -82.2 +29.4 +26.4% Apr 1, 2022 Jun 30, 2022
Q1 2022 -76.4 -24.9 -48.3% Jan 1, 2022 Mar 31, 2022
Q4 2021 -92.3 -40.8 -79.2% Oct 1, 2021 Dec 31, 2021
Q3 2021 -108 -67 -162% Jul 1, 2021 Sep 30, 2021
Q2 2021 -112 -77.3 -226% Apr 1, 2021 Jun 30, 2021
Q1 2021 -51.5 +58.2 +53% Jan 1, 2021 Mar 31, 2021
Q4 2020 -51.5 -13.2 -34.6% Oct 1, 2020 Dec 31, 2020
Q3 2020 -41.4 -1.06 -2.63% Jul 1, 2020 Sep 30, 2020
Q2 2020 -34.3 +1.32 +3.71% Apr 1, 2020 Jun 30, 2020
Q1 2020 -110 -74 -207% Jan 1, 2020 Mar 31, 2020
Q4 2019 -38.3 +66.2 +63.4% Oct 1, 2019 Dec 31, 2019
Q3 2019 -40.4 +38.9 +49.1% Jul 1, 2019 Sep 30, 2019
Q2 2019 -35.6 +31.3 +46.8% Apr 1, 2019 Jun 30, 2019
Q1 2019 -35.7 +31.9 +47.2% Jan 1, 2019 Mar 31, 2019
Q4 2018 -104 -37.1 -55% Oct 1, 2018 Dec 31, 2018
Q3 2018 -79.2 -13.3 -20.1% Jul 1, 2018 Sep 30, 2018
Q2 2018 -66.9 -9.59 -16.7% Apr 1, 2018 Jun 30, 2018
Q1 2018 -67.7 -27.3 -67.7% Jan 1, 2018 Mar 31, 2018
Q4 2017 -67.4 -39.5 -141% Oct 1, 2017 Dec 31, 2017
Q3 2017 -66 -44.9 -213% Jul 1, 2017 Sep 30, 2017
Q2 2017 -57.3 -38.6 -206% Apr 1, 2017 Jun 30, 2017
Q1 2017 -40.3 -22.8 -129% Jan 1, 2017 Mar 31, 2017
Q4 2016 -28 -11.9 -74.5% Oct 1, 2016 Dec 31, 2016
Q3 2016 -21.1 -4.16 -24.6% Jul 1, 2016 Sep 30, 2016
Q2 2016 -18.7 +1.69 +8.28% Apr 1, 2016 Jun 30, 2016
Q1 2016 -17.6 +9.14 +34.2% Jan 1, 2016 Mar 31, 2016
Q4 2015 -16 +26.4 +62.2% Oct 1, 2015 Dec 31, 2015
Q3 2015 -16.9 +35.7 +67.9% Jul 1, 2015 Sep 30, 2015
Q2 2015 -20.4 +21.7 +51.5% Apr 1, 2015 Jun 30, 2015
Q1 2015 -26.7 +20 +42.8% Jan 1, 2015 Mar 31, 2015
Q4 2014 -42.4 Oct 1, 2014 Dec 31, 2014
Q3 2014 -52.6 Jul 1, 2014 Sep 30, 2014
Q2 2014 -42.1 Apr 1, 2014 Jun 30, 2014
Q1 2014 -46.7 Jan 1, 2014 Mar 31, 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.